Amgen Inc. (AMGN)
5 new today)|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Amgen Inc. (AMGN)
289 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on AMGN
- SA Editor Miriam Metzinger(41)
- Centient Biotech Investor(30)
- Mike Huckman(21)
- SA Editors(16)
- SA Editor Eli Hoffmann(15)
Most popular authors
(tracked in watchlists)
- David Fry(1218)
- Bespoke Investment Group(679)
- SA Editor Eli Hoffmann(413)
- Andrew Wilkinson(407)
- Roger Nusbaum(405)
Most commented on authors
- SA Editor Eli Hoffmann(55)
- Alan Brochstein(32)
- Ohad Hammer(32)
- Bespoke Investment Group(29)
- Mark Perry(21)
- Hedge Fund Portfolio Tracking: Renaissance Technologies (Jim Simons), Q3 2008
- 9 Possible Pharma Deals for 2009
- 2009: Positive Outlook for Biotech
- Taking Advantage of Biotech Sector with ETFs
- 2008 Stock Market: 51 Rays of Light
- New Index of Health Product Innovators
- S&P's Best and Worst of 2008
- 4 Drug Stocks Trading Above Moving Averages
- Hedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008
- Five Highly Rated Healthcare Cost Containment Stocks
- Five Things Worth Remembering About Healthcare in 2009
- FDA Calendar Update: High Hopes for Amgen's Bone Drug
- Hedge Fund Tracking: Bruce Kovner's Caxton Associates, Q3 2008
- Merck BioVentures Enters the Generic Biotech Game
- More Focused Defensive Index
- Nine Pharma Predictions for 2009
- Three-Month, Updated FDA Decision Calendar
- Hedge Fund Tracking: John Griffin's Blue Ridge Capital, Q3 2008
- 11 Updated Stocks and the Sad Story They Tell
- Stocks Will Continue to Erode In This Busted Economy
- Healthcare Stock Opportunities In a Down Market
- 73 Decision Dates on Updated FDA Calendar
- Hedge Fund Tracking: Lee Ainslie's Maverick Capital, Q3 2008
- Markets Strike Fresh Lows
- What Are Some of the Best Hedge Fund Managers Doing?
- Biotech ETFs a Rare Safe Haven
- Who Will Take GM's Place in the Dow?
- Fast Money Recap - Will Goldman Be Tarnished? (11/10/08)
- Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
- Amgen: Remember Its Biotech Bloodlines?
- Boning Up on Amgen's D-mab for Osteoporosis
- Backlog of Decisions Is Building at the FDA
- October Stock Performance
- Only Abatement of Risk Aversion Will Stop VIX from Further Fall - JP Morgan Strategist
- Best and Worst Performing S&P 500 Stocks, YTD
- 60 Defensive Growth Stocks
- Looking at Last Week's Weakness, and What It Could Mean
- Unfairly Punished - Fast Money Recap (10/24/08)
- Market Trims Hedges - Fast Money Recap (10/23/08)
- Wall Street Breakfast: Must-Know News
- Amgen Answering the $30B Riddle
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Trading Center
- Free E-Newsletters
- About Seeking Alpha
- About Us
- Contact Us
- What's New
- Readers Feedback
- Advertise With Us
- Contributors
- Contribute an Article
- Feature Your Book
- Our Contributors
- Anonymous Contributions
- Dispute an Article?
- Legal
- Terms of Use
- Privacy
- Copyright